Diabetes news

 2018-12-11

This New App is Designed to Make Tracking Your Insulin Easier


If you use Lilly brand insulin, this new connected platform is designed to make tracking your diabetes data a lot easier. MORE

Explore the Beyond Type 2 Community


Join the Beyond Type 2 Community, a safe space for those with Type 2 diabetes to connect, share experiences, and get questions answered.MORE

Say Hello to BeyondType2.org in French, German and Italian!


BeyondType2.org now offers critical resources in five languages for people living with and impacted by type 2 diabetes.MORE
UnitedHealthcare $0 copay

UnitedHealthcare Announces $0 Copay on Insulin, Glucagon + More, Beginning in 2023


UnitedHealthcare announced a $0 copay on insulin, glucagon and other drugs starting in 2023. Here's what that could mean for UHC members.MORE
ADA2022

Research: Practical Use of Closed-Loop Insulin Pumps


Closed-loop insulin pump technology is a game-changer for those taking insulin. Here are essential tips to using them in day-to-day life.MORE
ADA2022

Weight Management + Type 2 Diabetes: Using Compassion, Medicine and Surgery


Weight loss has several benefits for people with type 2 diabetes. However, it isn’t always easy to achieve through only lifestyle changes.MORE
ADA2022

The Future of Insulin — Will It Be Affordable for the People Who Need It?


Research is showing promising advancements with new weekly oral and injectable insulins—but will they actually be affordable?MORE
ADA2022

Diabetes + Dementia: Using Nasal Insulin to Improve Brain Function


With rising rates of obesity in both type 1 and type 2 diabetes, understanding the impact on long-term brain health and function is critical.MORE
ADA2022

Reaching Everyone—Health Disparities in Physical Activity


People living with diabetes are told to just exercise more to better manage their diabetes. Here is why it's not that simple. MORE
ADA2022

Race, Racism, and Diabetes Research


Diabetes care and research is still drastically impacted by racist practices. It’s time to call the racism out. MORE
ADA2022

Mounjaro: Its Powerful Potential to Treat Type 2 Diabetes & Obesity


Experts discuss the impressive impact and future potential of using Mounjaro (tirzepatide) to treat obesity and type 2 diabetes.MORE
ADA2022

Diabetes Standards of Care Updated for Preventing or Delaying Type 2 Diabetes


The ADA has updated the standards of care to include recommendations that focus on preventing or delaying type 2 diabetes and its associated complications.MORE
ADA2022

Another Reminder that Racial/Ethnic Inequality Exists in Diabetes Care


Despite the variety of diabetes medications and technology, race and ethnicity still weigh heavily on a person’s access to these life-saving tools.MORE
ADA2022

Access to Insulin: In the United States


Despite the growing variety of insulin and technology, access to this life-saving drug continues to be a dire problem in the United States.MORE
ADA2022

Access to Insulin: In Low-Income Countries


In many countries, a person with diabetes may walk for four days to get a vial of short-acting insulin and seven to 10 days for long-acting.MORE
ATTD 2022

Research Suggests Changing Treatment Approach for Type 2 Diabetes 


With more medication and technology available for treating type 2 diabetes, it's about time more providers make better use of them. MORE

FDA Approves Lilly’s Mounjaro: First of its Kind Medication for Treatment of Type 2 Diabetes


The FDA approved Mounjaro from Lilly, the first GIP/ GLP-1 receptor agonist to treat people with type 2 diabetes. MORE
Tirzepatide research

Promising New Drug Leads to 22.5% Weight Loss in Adults Living with Obesity


The latest study on a new drug is making headlines for its impressive ability to help patients lose weight.MORE

Despite Universal Healthcare, Diabetes Disparities Persists in the United Kingdom


To address the racial and economic divide in diabetes technology use, a top diabetes specialist urges a change in pump and CGM training.MORE

ATTD 2022 Coverage: Advanced Technologies + Treatments for Diabetes


ATTD's annual conference covers the latest in diabetes technology and treatment. This year's event is in Barcelona from April 27-30, 2022. MORE

Coverage of Dexcom G6 CGM Now Improved with TRICARE


TRICARE healthcare members can now receive the Dexcom G6 continuous glucose monitor (CGM) under pharmacy benefits.MORE

The Rise of Prediabetes Diagnoses


There has been an increase in the number of people diagnosed with prediabetes. We spoke with Dr. Mayer B. Davidson to learn why.MORE

Beyond Type 1 Names Deborah Dugan as New CEO


Global diabetes nonprofit Beyond Type 1 has announced the appointment of its new CEO Deborah Dugan, former CEO of (RED).MORE
A SECOND COVID-19 BOOSTER DOSE + THE LATEST OMICRON VARIANT

A Second COVID-19 Booster Dose + The Latest Omicron Variant


Keeping up with the latest COVID-19 shot and variant news can be difficult. Here’s what you should know about Omicron XE and a second booster!MORE

A1c Test Results Are More Likely To Be Inaccurate for People Of Color–Here’s Why That Matters


A1c is one of the go-to tests for monitoring blood sugar, yet for people of African, South and Southeast Asian and Mediterranean ancestry, there’s a higher chance it’s not accurate.MORE
insulin now act

The Affordable Insulin Now Act: A Step Toward Federal Legislation


The Affordable Insulin Now Act, if passed in its current form, could help bring down the cost of insulin for millions of insured people with diabetes.MORE

FreeStyle Libre 2 Now More Easily Accessible for Military Members Through TRICARE


Military members with TRICARE now have easier access to Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM).MORE

Civica Rx Aims to Bring $30 Insulin to Market in 2024


Launching to market in 2024, Civica Rx aims to make insulin available for no more than $30 per vial, regardless of insurance status.MORE
Breakthrough Device Designation

COVID-19 Pushes FDA Approval of Breakthrough Device Designation for Dexcom CGM in Hospital Settings


The FDA has granted Breakthrough Device Designation for Dexcom CGM in hospital settings after the pandemic highlighted essential care needs for patients with diabetes.MORE
insulin type 2 diabetes emergency glucagon

If You Take Insulin for Type 2 Diabetes, Your Doctor Should Also Prescribe This…


If you take insulin as a person with type 2 diabetes, your healthcare provider should prescribe emergency glucagon, too. Here’s why…MORE
Eversense E3

Eversense E3 Continuous Glucose Monitor Gains FDA Approval, Offers Extended Wear-Time


The Eversense E3 continuous glucose monitor (CGM) is an exciting advancement for the diabetes community, with improved wear-time and accuracy.MORE
Drug Pricing Investigation

Inside the Drug Pricing Investigation from the House Oversight and Reform Committee


The results of the most recent report from the committee make things clear for the United States—the need for access to affordable healthcare is direr than ever.MORE
Mark Cuban Pharmacy

Mark Cuban’s New Online Pharmacy Provides Affordable Access to Some Common Prescription Drugs


Mark Cuban's latest investment in the pharmaceutical industry offers common generic prescription medications (not including insulin) at a fraction of the cost.MORE

Lilly Issues Voluntary Nationwide Recall of One Lot of Glucagon Emergency Kit


Lilly Diabetes announced the voluntary recall of lot D239382D, Expiration April 2022 of Glucagon Emergency Kits.MORE
Latinx Diabetes Initiative

The Latinx Diabetes Initiative Provides Culturally Tailored Care To Latinx Patients With Diabetes


Andreina Millan Ferro is centering culturally sensitive diabetes care for Latinx patients with diabetes at the Latinx Diabetes Initiative.MORE
gvoke hypopen

All About Gvoke HypoPen®


Anyone who takes insulin and other medications that cause low blood sugar should know about the premixed insulin Gvoke HypoPen.MORE
Yarishdy Mora

Empowering Youth Through Diabetes Education In Mexico


Yarishdy Mora is the director of the Youth Health Program for Project HOPE in Mexico. She creates platforms that help youth learn about diabetes. MORE
Screened for Type 2 Diabetes

Overweight Adults to Now Be Screened for Type 2 Diabetes At 35


The U.S. Preventive Services Task Force now recommends overweight and obese adults to get screened for Type 2 diabetes at the age of 35.MORE

The 2021 Association of Diabetes Care and Education Specialists (ADCES) Virtual Conference


The Beyond Type 2 team covered the virtual 2021 ADCES Conference, covering the latest in diabetes education for the T2D community.MORE
pandemic homelessness

Pandemic Homelessness Disproportionately Impacts People With Diabetes


An American Diabetes Association report found that pandemic homelessness hit people with diabetes 48 times harder.MORE

Youth with T2D Experience Long-Term Complications By Young Adulthood


Type 2 diabetes cases are rising in children and we're starting to learn they experience long-term complications by young adulthood. MORE

Abbott’s FreeStyle Libre 2 App Receives FDA Clearance


On August 2, 2021, the FDA approved the FreeStyle Libre 2 app for adults and children with diabetes, allowing user to access glucose readings directly from their iPhone.MORE
senza

FDA Approves Senza®, Nevro’s High Frequency Spinal Cord Stimulation Therapy For PDN


The Senza System has been approved by the FDA for the treatment of chronic pain associated with painful diabetic neuropathy. MORE
semglee

Semglee Receives FDA Approval as First Interchangeable Biosimilar Insulin


Semglee becomes the first interchangeable biosimilar product for the treatment of Type 1 and Type 2 diabetes.MORE
Culturally Sensitive LGBTQ+ Diabetes Health Care

Providing Culturally Sensitive LGBTQ+ Diabetes Health Care


Culturally sensitive LGBTQ+ diabetes health care can decrease stigma and advance diabetes care access for the LGBTQ community. MORE
Kerendia

FDA Approves Kerendia For The Treatment Of Type 2 Diabetes


Kerendia will be available in the U.S. immediately for the treatment of chronic kidney disease associated with Type 2 diabetes.MORE
surgeon preparing for pancreas transplant

Research on Pancreas Transplants in Type 1 and Type 2 Diabetes


Pancreas transplants are not an easy solution to type 1 or type 2 diabetes, but for some, they may be life-saving.MORE

Healthcare Providers Will No Longer Be Allowed to Issue “Surprise” Bills


Editor’s Note: People who take insulin require consistently affordable and predictable sources of insulin at all times. If you or a loved one are struggling to afford or access insulin, you can buil...MORE
Walmart NovoLog

Walmart Launches Lower-Cost Analog Insulin: ReliOn NovoLog


ReliOn NovoLog will be available at Walmart and Sam's Club pharmacies for $72.88 per vial and $85.88 per box of five FlexPens.MORE
diabetes prevention program

Effects of Medicaid Coverage on the Diabetes Prevention Program in California


Obidiugwu K. Duru presents at the 81st ADA conference on how medicaid impacts the California Diabetes Prevention Program.MORE

News from DiabetesMine™ D-Data Exchange 2021


D-Data is the event, where attendees can discover, learn about, and try demos of new diabetes tech. Here is a recap of the sessions we attended at D-Data 2021.MORE
Zegalogue®

Zegalogue® Is Now Commercially Available in the United States


Zegalogue®, also known as dasiglucagon, is now commercially available in the U.S. for the treatment of severe hypoglycemia.MORE

Breaking News from ADA 2021


Breaking news from the biggest diabetes conference of the year - the American Diabetes Association's 81st Scientific Sessions.MORE

American Diabetes Association’s 81st Annual Scientific Sessions: #ADA2021


The biggest diabetes conference of the year is virtual for the second year + Beyond Type 2 is reporting live! Keep up with our coverage here. MORE
continuous glucose monitor coverage

Medicare Loosens Restrictions On Continuous Glucose Monitor Coverage


Medicare revised its local coverage determination policy to remove requirements for continuous glucose monitor coverage.MORE

Over Insulin Pricing, Mississippi AG Sues Insulin Manufacturers and Pharmacy Benefit Managers


MS attorney general Lynn Fitch filed a lawsuit against PBMs & insulin manufacturers for allegedly working together to inflate insulin prices.MORE
ACA intact

Supreme Court Votes To Keep The ACA Intact


The Affordable Care Act (ACA) provides health care to millions of Americans. The Supreme Court voted 7-2 to keep the ACA intact.MORE
omnipod 5

Omnipod 5 Pivotal Trial Data Published


Data from the pivotal trial shows that the Omnipod 5 improves time-in-range, and reduces HbA1c and mean glucose levels. MORE
lessons about diabetes

ATTD 2021: Lessons About Diabetes During The COVID-19 Pandemic


ATTD 2021 took place from June 2-5. Dr. Irl Hirsch shares his lessons about diabetes during the COVID-19 pandemic.MORE
ATTD 2021

Breaking News From ATTD 2021


This year, ATTD 2021 will be held virtually where developers and clinicians will present their new diabetes technology and research.MORE
sharp drop in a1c testing due to telehealth

COVID Pandemic Leads to a Sharp Drop in A1c Testing


"We started getting a lot of referrals with really high A1cs in the double-digits,” says Jennifer Okemah, MS, RD, BCADM, CDCES, CSSDMORE

Researchers Find That CGMs Provide Insight On The Progression Of Type 2 Diabetes Among Hispanic Adults


Researchers break down the importance of CGMs in understanding diabetes and how to tackle accessibility barriers among Hispanic adults. MORE
bullying

Combating Bullying: How One Person With Diabetes Fought To Test Her Blood Sugar In The Workplace


Sheri Byrne shares her experience on how she fought workplace bullying due to diabetes and advocated for herself.MORE
Bigfoot Unity

Bigfoot Unity™ Diabetes Management System Receives The Green Light From The FDA


Bigfoot Unity™, a one-of-a-kind diabetes management system with smart pen caps received FDA approval on May 10, 2021 and will reach select diabetes clinics this spring. MORE

Asian Isn’t A Monolith: Why More Specific Data Matters in Diabetes Research


Data on how diabetes impacts specific ethnic groups could help us better support people within Asian American Pacific Islander communities.MORE
ramadan

Diabetes + Ramadan: Here’s How a Few People Are Observing


People with diabetes face their own set of challenges when observing Ramadan. Two people with diabetes share their experiences. MORE
aapi diabetes research

Chris Hahm’s Uphill Battle: The Severe Underfunding of AAPI Diabetes Research


H. Chris Hahm shares her challenges of conducting diabetes research focused on the AAPI community, research that is severely underfunded.MORE

Doctors Agree: They Need More Time with Type 2 Diabetes Patients


90% of doctors want more time with Type 2 diabetes patients and better communication between specialists regarding each patient.MORE

Two Pillars in the Diabetes Community Unite to Serve Millions Living with Diabetes


The partnership will feature combined resources, strategies, and tactics to better serve people living with type 1 diabetes, type 2 diabetes, and prediabetes.MORE

Priyanka Chopra Jonas Joins the Board of Directors at Beyond Type 1


Priyanka Chopra Jonas brings energy and expertise to Beyond Type 1 as it initiates new efforts to serve the diabetes community globally.MORE

Inside the Senate Report on Rising Insulin Prices


A January 2021 Senate Finance Committee report dug into the rapidly increasing cost of insulin. Here, we summarize and explain their findings.MORE

What to Know About the 2021 Standards of Care for Type 2 Diabetes


It's important to know which guidelines doctors follow to develop your treatment plans. Here's what to know about the 2021 Standards of Care.MORE

Get the Facts on Insulin Pricing + The Presidential Transition


A flurry of misinformation is stoking fears that the Biden Admin paused or reversed a previous Trump Admin policy that lowered the price of insulin. MORE

New Year, New Administration: What’s Coming For US Healthcare Policy


With a new governmental administration, it is likely we will see notable and impactful movement in healthcare policy. What can we expect? MORE

Beyond Type 2 Celebrates Two Years, Launches New Community Platform


Today, global diabetes nonprofit Beyond Type 1 celebrates the two year anniversary of the launch of Beyond Type 2 - a digital platform for those impacted by Type 2 diabetes, available in English and S...MORE

Study Finds Lilly’s Tirzepatide Reduces A1C and Body Weight


After a 52-week treatment plan, a study conducted by Eli Lilly and Company found that their new medication tirzepatide significantly reduced A1C and body weight in adults with Type 2 diabetes.MORE

Diabetes + COVID Vaccines: What You Need to Know


If you have diabetes, here’s what you need to know about the COVID-19 vaccines, including safety, timeline, and how to get yours.MORE

Amazon Launches Online Pharmacy


Amazon Pharmacy, launched on November 17, delivers medications and prescription refills - such as insulin - with Prime membership 2-day shipping.MORE

January AI Looks to Revolutionize Personalized Diabetes Care


January AI is a precision health company designed to encourage small lifestyle changes and habit-building. Founder and CEO, Noosheen Hashemi, spoke with Beyond Type 2 about the company and its future.MORE

Talking COVID-19’s Impact on ADCES with President Kellie Antinori-Lent


ADCES President Kellie Antinori-Lent talks to Beyond Type 2 about moving the ADCES Annual Conference to a virtual platform due to the COVID-19 pandemic, how diabetes care and education specialists are...MORE

Use of Technology in Underserved Populations


Dr. Anne Peters is a professor of clinical medicine at the Keck School at USC, Director of the USC Clinical Diabetes Programs, and she works with Los Angeles County and on a diabetes program.MORE

An Interview with ADCES 2020 Innovative Use of Technology Award Winner, Molly Wagman


2020 Innovative Use of Technology Award winner, Molly Wagman, MS, RDN, CSSD, CDCES, talks to Beyond Type 2 about using mySugr to improve the lives of diabetes patients. MORE

The Association of Diabetes Care and Education Specialists (ADCES) Virtual Conference


Every summer, the Association of Diabetes Care and Education Specialists’ (ADCES) holds their annual conference where original research is presented, important topics in diabetes care are discus...MORE

Study Shows Meal Replacement Shakes Improve T2D Glucose Management


New study reveals twice-daily meal replacement shakes improve glucose management in people with type 2 diabetes who are on oral medication. MORE

White House Issues Executive Orders Taking Aim at Drug Prices


On Friday, July 24 President Trump announced and signed four Executive Orders aimed at lowering prescription drug prices in the U.S.MORE

Diabetes Prevention Program Shows Persistent Reduction of Type 2 Diabetes Development


A 22-year follow up on the Diabetes Prevention Program Outcomes Study (DPPOS) indicates a continued significant reduction in the participants’ risk of developing Type 2 diabetes. Individuals in the...MORE

Lifestyle Interventions for Type 2 Diabetes Remission


Type 2 diabetes remission is a hot topic within the T2D community. At the American Diabetes Association's 80th Scientific Sessions, researchers presented data on the impact lifestyle intervention...MORE

Disparities in Diabetes and Diabetes Care—What Can We Do About It?


At this ADA 2020 session, systemic racism and implicit bias were clear contributors to poor health and healthcare outcomes for Black and Latinx communities.MORE

Dapagliflozin May Reduce the Onset of Type 2 Diabetes


Research presented at the American Diabetes Association's 80th Scientific Sessions revealed that the SGLT-2 Inhibitor, dapagliflozin, may reduce the onset of Type 2 diabetes when used in patients...MORE

Who Has Access to New Oral Diabetes Medications?


Racial and ethnic minorities may have a greater need for newer diabetes medications but functionally have less access. MORE

FreeStyle Libre 2 Approved for Use in U.S.


The FreeStyle Libre 2 is a 14 day CGM system that transmits data every minute and now includes customizable high and low alerts without the need to scan the device. The Abbott announcement says it wil...MORE

Nationwide Study in France Shows Dramatic Drop in DKA in Type 1 and Type 2 after Starting on FreeStyle Libre


The study included more that 70,000 patients living with diabetes and DKA rates were reduced by 52% for patients with T1D and 47% for patients with T2D.MORE

Closed Loop Updates: Omnipod Horizon and Medtronic 780G data presented at ADA 2020


Data from four new clinical trials involving Hybrid Closed Loop systems, Medtronic 780G and Omnipod 5 Powered by Horizon was presented at ADA 2020.MORE

Breaking News From ADA 2020


Medtronic presented results from its U.S. pivotal trial of its investigational MiniMed™ 780G Advanced Hybrid Closed Loop (AHCL) system. Results of the 90-day showed improved A1C, Time in Range, and ...MORE

How Omnipod Simplifies Life with Type 2 Diabetes: A Chat with Insulet CCO Bret Christensen


Bret Christensen is the Chief Commercial Officer at Insulet, maker of the Omnipod Insulin Management System. He recently spoke with Beyond Type 2 to discuss his role at the company, how Insulet is ove...MORE

News From DiabetesMine™ D-Data Exchange 2020


The Beyond Type 2 team is spending a day at The DiabetesMine™ D-Data ExChange – this is our report from this enlightening event. MORE

American Diabetes Association’s 80th Annual Scientific Sessions: #ADA2020


The biggest diabetes conference of the year is taking place virtually and Beyond Type 2 is reporting live! Learn more, stay tuned.MORE

Medicare Part D Senior Savings Model Caps Insulin Costs at $35 per Month


The Senior Savings Model caps out of pocket insulin costs at $35 per month for seniors enrolled in eligible plans.MORE

England’s NHS Releases Study on Risk of COVID-19 for People with Diabetes


This week, the National Health Service (NHS) in England released the first study of its kind, breaking down COVID-19 mortality risk by type of diabetes.MORE

Severe Low Blood Sugar Community Survey


In order to build effective resources, we want to hear from YOU. Tell us about your knowledge and experiences with Severe Hypoglycemia below!MORE